- Home
- ARMP vs PMVP Comparison
ARMP vs PMVP Comparison
Compare ARMP & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- PMVP
- Stock Information
- Founded
- ARMP 2016
- PMVP 2013
- Country
- ARMP United States
- PMVP United States
- Employees
- ARMP N/A
- PMVP N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ARMP Health Care
- PMVP Health Care
- Exchange
- ARMP Nasdaq
- PMVP Nasdaq
- Market Cap
- ARMP 73.8M
- PMVP 71.9M
- IPO Year
- ARMP N/A
- PMVP 2020
- Fundamental
- Price
- ARMP $1.58
- PMVP $1.11
- Analyst Decision
- ARMP Strong Buy
- PMVP Strong Buy
- Analyst Count
- ARMP 1
- PMVP 3
- Target Price
- ARMP $7.00
- PMVP $5.33
- AVG Volume (30 Days)
- ARMP 15.2K
- PMVP 105.8K
- Earning Date
- ARMP 03-20-2025
- PMVP 03-03-2025
- Dividend Yield
- ARMP N/A
- PMVP N/A
- EPS Growth
- ARMP N/A
- PMVP N/A
- EPS
- ARMP N/A
- PMVP N/A
- Revenue
- ARMP $5,174,000.00
- PMVP N/A
- Revenue This Year
- ARMP $8.43
- PMVP N/A
- Revenue Next Year
- ARMP N/A
- PMVP N/A
- P/E Ratio
- ARMP N/A
- PMVP N/A
- Revenue Growth
- ARMP 14.24
- PMVP N/A
- 52 Week Low
- ARMP $1.58
- PMVP $1.11
- 52 Week High
- ARMP $4.25
- PMVP $2.26
- Technical
- Relative Strength Index (RSI)
- ARMP 30.25
- PMVP 26.51
- Support Level
- ARMP $1.63
- PMVP $1.21
- Resistance Level
- ARMP $2.30
- PMVP $1.30
- Average True Range (ATR)
- ARMP 0.15
- PMVP 0.06
- MACD
- ARMP -0.04
- PMVP -0.01
- Stochastic Oscillator
- ARMP 0.00
- PMVP 0.00
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.